España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Recent
Markets
Caroline Levy
Macquarie Turns Bullish On Kimberly Clark: 'We Are More Confident In The Sales Growth Outlook'
Beverage Stocks: Macquarie Bullish On Diageo, Pepsi, But Says Constellation's Asset Sale Was Underpriced
Analyst: Constellation's Wine Sale Will Likely Be Dilutive For 3 Years
Beverage Stocks: Macquarie Bullish On Diageo, Pepsi, But Says Constellation's Asset Sale Was Underpriced
Analyst: Constellation's Wine Sale Will Likely Be Dilutive For 3 Years
Mixing It Up: Keurig Dr. Pepper, Anheuser-Busch Expanding K-Cup Cocktail Effort
Analysts: Estée Lauder's Strength Isn't Just Cosmetic
Mixing It Up: Keurig Dr. Pepper, Anheuser-Busch Expanding K-Cup Cocktail Effort
|
Analysts: Estée Lauder's Strength Isn't Just Cosmetic
|
Monster Beverage Posts Sales, EPS Beat: 4 Sell-Side Takes
|
Procter & Gamble's CAGNY Presentation Turns Macquarie Incrementally Bullish
|
Read More...
Caroline Levy Recent News
'They've Got To Diversify': Anheuser-Busch Buys Liquor, Canned Cocktail Company Cutwater
|
Macquarie Raises A Glass To Boston Beer, Upgrades After Q4 EPS Beat
|
Macquarie Remains Cautious On Constellation Ahead Of Cannabis-Related Losses
|
Why Macquarie Prefers Pepsi Over Coca-Cola
|
Estee Lauder: Analysts Mostly Bullish On Q2 Results, Despite Weak Guidance
|
The Alcohol Market's Changing Chemistry: Younger, Healthier Drinkers Want Options
|
Analysts Like Procter And Gamble Sales Numbers, Dislike Margins
|
Macquarie: Coca-Cola European Partners Faces Downside Risk From UK Plastic Regulations
|
5 Risks Cannabis Investors Need To Understand
|
Macquarie: Coca-Cola A Winner With BodyArmor Investment As Pepsi's Gatorade Cedes Share
|
Macquarie: Diageo Poised For Higher American Sales, Market Share
|
Macquarie Cautious On Constellation's Cannabis Investment
|
The Latest Trends In Alcohol: Panel Sees Rise In Hard Seltzer, Spirits
|
A US Beer Industry Review: Seltzers Sizzle, Big Domestic Brands Fall Out Of Favor
|
Analysts Weigh In On Anheuser Busch Earnings, Dividend Cut
|
The Street's Reaction To Constellation's Q2 Earnings
|
Macquarie Turns Sour On PepsiCo, Downgrades Stock
|
Colgate-Palmolive's Weak Sales Growth 'Will Become The Norm,' Macquarie Says In Downgrade
|
Macquarie Upgrades Church & Dwight After Beat-and-Raise Quarter
|
Colgate-Palmolive Set To Outperform In 2018, According To Macquarie
|
Chinese Survey Has More Bad News Than Good For Estee Lauder
|
3 Takeaways From Recent IRI Retail Data
|
An Inflection Point In Anheuser Busch Inbev Is 'Imminent'
|